Results 161 to 170 of about 77,172 (303)

Outcome analysis of major cardiac operations in low weight neonates [PDF]

, 2004
Bové, Thierry, De Groote, Katya, De Wolf, Daniël, Francois, Katrien, Matthys, Dirk, MOERMAN, ANNELIESE, Poelaert, Jan, SUYS, B, Van Nooten, Guido, VANHAESEBROECK, P, Verhaaren, Henri   +10 more
core   +2 more sources

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source

Marfan’s syndrome with aneurysmal formation of the aortic root and ascending aorta concomitant with aortic valve regurgitation of patients undergoing Bentall operation: the first two cases in southern Thailand

Journal of Health Science and Medical Research (JHSMR), 2004
The aorta is considered as pathologically dilated when the diameter of the aortic root and ascending aorta exceed the normal for a given age and body size.
V Chittithavorn, C Rergkliang, A Chetpaophan, P Vasinanukorn, T Chanchayanon, V Vasinwong, J Katayjan, S Suwanugsorn, V Chintapakorn   +8 more
doaj  

Noncompaction Cardiomyopathy, Sick Sinus Disease, and Aortic Dilatation: Too Much for a Single Diagnosis? [PDF]

JACC Case Rep, 2022
Brunet-Garcia L, Odori A, Fell H, Field E, Roberts AM, Starling L, Kaski JP, Cervi E.   +7 more
europepmc   +1 more source

Metabolic abnormalities and reprogramming in cats with naturally occurring hypertrophic cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1256-1270, April 2025.
Abstract Background and aims The heart is a metabolic organ rich in mitochondria. The failing heart reprograms to utilize different energy substrates, which increase its oxygen consumption. These adaptive changes contribute to increased oxidative stress.
Qinghong Li, Max Homilius, Erin Achilles, Laura K. Massey, Victoria Convey, Åsa Ohlsson, Ingrid Ljungvall, Jens Häggström, Brittany Vester Boler, Pascal Steiner, Sharlene Day, Calum A. MacRae, Mark A. Oyama   +12 more
wiley   +1 more source

Association of immunological parameters with aortic dilatation in giant cell arteritis: a cross-sectional study. [PDF]

Rheumatol Int, 2023
Jud P, Verheyen N, Stradner MH, Dejaco C, Szolar D, Thonhofer R, Schweiger L, Brodmann M, Hafner F.   +8 more
europepmc   +1 more source

Prognostic role of TAPSE to PASP ratio in outpatients with left ventricular systolic dysfunction

ESC Heart Failure, Volume 12, Issue 2, Page 912-922, April 2025.
Abstract Aims Few data are available regarding the role of tricuspid annulus plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP), a measurement of right ventricular to pulmonary artery coupling, in patients with chronic heart failure and left ventricular systolic dysfunction.
Mauro Riccardi, Matteo Pagnesi, Rossana Corso, Antonio M. Sammartino, Daniela Tomasoni, Riccardo M. Inciardi, Carlo M. Lombardi, Marianna Adamo, Savina Nodari, Marco Metra   +9 more
wiley   +1 more source

Performance of a deep learning tool to detect missed aortic dilatation in a large chest CT cohort. [PDF]

Front Cardiovasc Med, 2022
Pradella M, Achermann R, Sperl JI, Kärgel R, Rapaka S, Cyriac J, Yang S, Sommer G, Stieltjes B, Bremerich J, Brantner P, Sauter AW.   +11 more
europepmc   +1 more source

A phenomap of TTR amyloidosis to aid diagnostic screening

ESC Heart Failure, Volume 12, Issue 2, Page 1113-1118, April 2025.
Abstract Cardiac amyloidosis due to transthyretin (ATTR) remains an underdiagnosed cause of cardiomyopathy. As awareness of the disease grows and referrals for ATTR increase, clinicians are likely to encounter more atypical forms of the condition in clinical practice.
Alexios S. Antonopoulos, Theodoros Tsampras, George Lazaros, Konstantinos Tsioufis, Charalambos Vlachopoulos   +4 more
wiley   +1 more source

Glycoprotein and Lipoprotein Profiles Assessed by 1H-NMR and Its Relation to Ascending Aortic Dilatation in Bicuspid Aortic Valve Disease. [PDF]

J Clin Med, 2022
Antequera-González B, Faiges M, Martínez-Micaelo N, Galian-Gay L, Ligero C, Ferré-Vallverdú M, Masana L, Amigó N, Evangelista A, Alegret JM.   +9 more
europepmc   +1 more source